Douglas L. Packer - Researcher Profile

Publications

4 shown

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary

Hugh Calkins , Gerhard Hindricks , Riccardo Cappato +57 more

Symptomatic AF prior to initiation of antiarrhythmic therapy with a Class I or III antiarrhythmic medication Paroxysmal: Surgical ablation is reasonable.IIa

2017 EP Europace 491 citations

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design

Hugh Calkins , Carlo Pappone , Riccardo Cappato +39 more

2012 Heart Rhythm 1450 citations

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Gust H. Bardy , Kerry L. Lee , Daniel B. Mark +14 more

In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas single-lead, shock-only ICD therapy reduces ove...

2005 New England Journal of Medicine 6444 citations

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation

Douglas L. Packer , Daniel B. Mark , Richard A. Robb +26 more

ClinicalTrials.gov Identifier: NCT00911508.

2019 JAMA 1346 citations

Frequent Co-Authors

Researcher Info

h-index: 4
Publications: 4
Citations: 9,731
Institution: Mayo Clinic in Arizona

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-2060-869X

Impact Metrics

h-index 4

h-index: Number of publications with at least h citations each.